Pharyngeal Squamous Cell Carcinoma

• CLINICAL_TRIALS trial_result · 2026-06-03
  Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]

  Phase 2/3 trial evaluating atezolizumab and/or bevacizumab with or without standard chemotherapy as second-line treatment for advanced head …

• CLINICAL_TRIALS research · 2026-02-24
  Clinical Trial Update: Microbiome in Head and Neck Squamous Cell Carcinoma

  This ClinicalTrials.gov update describes an ongoing study at University of Colorado, Denver examining the role of the microbiome in head and…

• CLINICAL_TRIALS research · 2025-06-06
  Clinical Trial Update: Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck [Phase 2]

  This is a Phase 2 clinical trial update examining nivolumab in combination with BMS986205 for stage II-IV squamous cell cancers of the head …

• CLINICAL_TRIALS trial_result · 2025-06-04
  Clinical Trial Update: A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy [Phase 2]

  This Phase II trial of PG2 in patients with advanced pharyngeal or laryngeal squamous cell carcinoma undergoing concurrent chemoradiotherapy…